Aldose reductase (AR), a member of the aldo-keto reductase family, has been demonstrated to play a central role in mediating myocardial ischemia-reperfusion (I/R) injury. Recently, using transgenic mice broadly over expressing human aldose reductase (ARTg), we demonstrated that AR is an important component of myocardial I/R injury and that inhibition of this enzyme protects heart from I/R injury. To rigorously delineate mechanisms by which AR pathway influences myocardial ischemic injury, we investigated the role played by ROS, antioxidant enzymes and mitochondrial permeability transition MPT pore opening in hearts from ARTg or littermates (WT) subjected to I/R. MPT pore opening after I/R was determined using mitochondrial uptake of 2-deoxyglucose (2-DG) ratio, while H2O2 was measured as a key indicator of ROS.
protects mitochondria and hence, may be a useful adjunct for salvaging ischemic myocardium.
INTRODUCTION
Mitochondria plays a key role in influencing cell death/survival, especially after a stress event in cardiac tissue (5, 8, 12, 63) . Mitochondria in ischemic and reperfused hearts have impaired function, a decreased adenine nucleotide content, reduced activities of adenine nucleotide translocasease (ANT) and oxidative phosphorylation enzymes, lower membrane potential, and decreased NADH dehydrogenase activity (8, 11, 13, 15, 16, 27, 29) .
Mitochondrial permeability transition (MPT), opening of non-selective pores spanning the mitochondrial matrix to the cytosol, has been implicated as a key event in myocardial ischemia-reperfusion injury. Opening of MPT pore occurs when the mitochondria is exposed to high calcium along with adenine nucleotide depletion, elevations in phosphate concentrations, membrane depolarization, and/or oxidative stress (5, 8, (11) (12) (13) 15, 16, 27, 29, 63) . Studies have implicated the MPT pore as a key determinant of cell survival (7, 11, 13, 15, 17, 27, 29, 44) . It has been shown that opening of MPT pore, indeed, plays an important role in necrosis and apoptosis after ischemia-reperfusion (7, 17, 27, 29, 44) .
Recent studies have demonstrated that polyol pathway or aldose reductase (AR) pathway is a key contributor to myocardial ischemia-reperfusion injury and that inhibition of AR protects myocardium from ischemia-reperfusion injury (20) (21) (22) 48, 49, 56) . Inhibition of AR resulted in improved energy homeostasis (20, 21, 48, 49) and attenuation of the changes in intracellular sodium and calcium (46) . Flux via AR has been shown to impact adversely on calcium homeostasis, increase oxidative stress, and impair energy homeostasis (14, 38, 39, 47, 61) . Since these conditions are ripe for MPT pore opening in myocardium after ischemia-reperfusion, we postulated modulation of MPT pore opening, in part, due to increases in ROS, is one mechanism by which AR pathway mediates myocardial ischemia-reperfusion injury. The AR protein activity in mice is several fold less than in the hearts of humans and rats (20, 47) . Hence, we employed transgenic mice expressing human AR with activity similar to those in humans (20, 47) . Using these mice, we show that that MPT opening, due in part to increases in reactive oxygen species is a key event by which AR pathway mediates myocardial ischemic injury.
METHODS
All studies were performed with the approval of the Institutional Animal Care and Use Committee at Columbia University, New York, and conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 1996) . Mice transgenic for human aldose reductase (ARTg)
were obtained from an established breeding colony at Columbia University. Briefly, these transgenic mice were developed by injecting full length human AR cDNA with a mouse major histocompatibility antigen class I promoter (20) . These transgenic mice have been backcrossed over 10 generations to obtain mice in the C57BL6 background and were used in our studies. The litters were routinely screened for hAR transgene expression by polymerase chain reaction (PCR) using primers and conditions described previously (20) We have recently conducted studies using these mice and have published in the literature (20) . Non-transgenic littermates (WT) were used as controls.
Ischemia/reperfusion protocol
Hearts were isolated and perfused with Krebs-Henseleit buffer, containing (in mM) NaCl 118, KCl 4.7, CaCl2 2.5, MgCl2 1.2, NaHCO3 25, 25, glucose 5, palmitate 0.4, BSA 0.4, and 70 mU/L insulin, as previously described (20) (21) (22) 45) . Left ventricular developed pressure (LVDP) and left ventricular end diastolic pressure (LVEDP) was continuously monitored as previously published (20) (21) (22) 45) . Hearts were paced at 420 beats/min using electrodes placed on the right atrium. After an equilibration period of 30 min, global ischemia was performed for 25 min in WT and ARTg mice hearts followed by 60 min of reperfusion.
The following groups of mice were studied: Untreated WT & ARTg: Hearts from WT and ARTg mice perfused with KrebsHenseleit buffer throughout the ischemia-reperfusion protocol.
ARTg-ARI:
Hearts from ARTg mice were perfused with modified Krebs-Henseleit buffer containing 100 μM zopolrestat (ARI -this dose gives free acid concentration of 1 μM) starting 10 min prior to ischemia and continued throughout ischemia and reperfusion. In specific experiments, appropriate WT mice were also perfused similarly with ARI as above. Zopolrestat concentration used here is based on our earlier studies (20) (21) (22) Cyclosporin treated: Hearts from WT (WT-CsA) and ARTg (ARTg-CsA) mice were perfused with Krebs-Henseleit buffer plus 0.2μM Cyclosporin A (CsA) (Sigma, St Louis) throughout the ischemia-reperfusion protocol.
Resveratrol treated:
Hearts from WT (WT-Res) and ARTg (ARTg-Res) mice were perfused with Krebs-Henseleit buffer containing 10μM resveratrol (Sigma) starting 10 min prior to ischemia and continued throughout ischemia and reperfusion.
Mitochondrial Studies

Measurement of the mitochondrial permeability transition pore (MPTP):
To determine influence of aldose reductase activity on mitochondrial permeability, 2-[ 3 H] deoxyglucose (2-DG) was used to measure MPTP in hearts according to published methods in the literature (27, 29) . Briefly, hearts were perfused in recirculating mode with 2-DG (0.1 μCi/ml) for 30 min, and were then perfused in the absence of 2-DG for 10 min in a non-recirculating mode. After subjecting the hearts to ischemia and reperfusion, tissues were rapidly excised, weighed, and homogenized in ice- 
Mitochondrial enzyme analysis
Isolated perfused hearts were analyzed for various mitochondrial enzymes associated with electron transport chain as described in the literature (35, 36, 43, 52) . Rotenone sensitive Comp I activity was measured by oxidation of NADH by Ubiquinone-1 at 340 nm, Complex IV activity was assayed by the oxidation of dithionite reduced cytochrome c at 550 nm, complex V (oligomycin -sensitive ATP synthase) determined by the oxidation of NADH in a coupled assay using pyruvate kinase and lactate dehydrogenase at 340nm. Citrate synthase (CS) was determined at 412nm.
Measurement of H2O2 Production
To investigate if AR pathway influences mitochondrial ROS generation in hearts after ischemia-reperfusion, we measured mitochondrial H2O2 using the oxidation of the 
Biochemical measurements:
GSH was measured in homogenate and mitochondrial fractions using the BiotechR GSH-412 TM kit (Oxis Research, Portland, OR). GSH content was determined in the samples as per manufacturer's instructions. Creatine kinase (CK) release, a marker of injury due to ischemia-reperfusion, was measured in effluents as published earlier (21) (22) (23) 48) . MDA and SOD activity in heart homogenates were determined using commercially available kits (MDA 586 and Bioxy Tech SOD-25 from Oxis International Inc.).
Statistical analysis
All data are presented as mean value± standard deviation. Statistical significance of differences between control and ARTg hearts were determined by ANOVA. Post hoc comparisons were performed with Tukey or Dunnett procedures using SAS package software as indicated. Statistical significance was ascribed to the data when P<0.05.
RESULTS
Mitochondrial pore opening during reperfusion in mice hearts
To determine if aldose reductase pathway influences MPT pore opening after ischemia-reperfusion, two methods were employed. In the first method, the determination of 2-DG-phosphate in the isolated mitochondria, a well-documented measure of MPT pore opening (27, 29) , was used. Under baseline perfusion conditions, mitochondrial entrapment of 2-DG was similar in wild type and ARTg mice hearts ( Figure 1a ). Mitochondrial entrapment of 2-DG was greater in hearts from ARTg ( Figure   1b ) than in wild type littermates after ischemia-reperfusion. Inhibition of AR with zopolrestat attenuated mitochondrial entrapment of 2-DG in ARTg hearts after ischemiareperfusion. Consistent with earlier studies (27, 29) , mitochondrial entrapment of 2-DG was significantly higher in ischemia-reperfusion condition than in baseline perfusion conditions.
In the second method, we monitored the swelling of mitochondria by measuring light scattering at 540 nm in the presence of varying amounts of added calcium. Figure   1c shows that at lower concentrations of calcium, the rate of swelling was greater in ARTg mice than in littermates. Pharmacological inhibition of aldose reductase blocked mitochondrial swelling in ARTg hearts at low calcium concentrations. Similar effects on swelling of mitochondria were observed in WT hearts treated with an ARI. At higher concentrations of calcium, cardiac mitochondria from all groups had relatively lower calcium induced changes in absorbance at 540nm, a finding consistent with earlier studies in mice (60) . Addition of cyclosporin A, known to inhibit the pore opening (11, 37) abolished the calcium induced swelling effects in mitochondria from ARTg, ARTg-ARI, and WT hearts (data not shown). The 2-DG entrapment studies and calcium induced swelling studies suggest that AR pathway influences MPT pore opening in mice hearts after ischemia-reperfusion.
Involvement of MPT pore in myocardial ischemic injury in AR mice hearts
Since cyclosporin A (CsA) has been shown to inhibit opening of MPT pores, we subjected hearts from ARTg and littermate mice to ischemia-reperfusion in the presence of CsA and determined if AR pathway influences myocardial ischemic injury via modulation of MPT pore. Creatine kinase (CK) release during reperfusion, a marker of ischemic injury, was measured in these studies. The data in Figure 2a shows that myocardial ischemic injury was greater in ARTg vs littermate hearts (p<0.05), a finding consistent with our earlier publication (20) . Myocardial ischemic injury was significantly reduced in CsA treated ARTg compared to untreated ARTg hearts (p<0.05). Similarly, in the littermate hearts, perfusion with CsA also resulted in significant reduction of ischemic injury ( Figure 2a ).
Reductions in ischemic injury due to MPT pore closing with CsA was associated with improved left ventricular developed pressure (LVDP) recovery after ischemiareperfusion. Data in Figure 2b demonstrates that inclusion of CsA in perfusion medium, improved LVDP recovery in both ARTg and littermate mice hearts. LVDP recovery was impaired in ARTg mice hearts compared to WT littermates (p<0.05). These data indicate that MPT pore opening impacts injury and LVDP recovery due to ischemia-reperfusion in mice hearts, with greater impact being observed in ARTg mice hearts.
Mitochondrial ROS
We investigated if AR mediates MPT pore opening, at least in part, via increasing oxidative stress. Mitochondrial and total GSH content was significantly reduced in ARTg mice hearts than in wild type (Figure 3 a,b ) (p<0.05) Activity of MnSOD was significantly reduced in ARTg mice hearts, compared to wild type, after ischemiareperfusion ( Figure 4a ). Changes in activities and expression of catalase were similar in ARTg and wild type mice hearts subjected to ischemia-reperfusion (data not shown).
Malonaldialdehyde (MDA) levels were significantly greater in ARTg than in wild type mice after ischemia-reperfusion (figure 4 b). Inhibition of AR with ARI, reduced MDA content in ARTg (p<0.05) vs WT mice exposed to ischemia-reperfusion (Fig 4b) .
Since reduced GSH content along with changes in antioxidant enzyme activities in mitochondria promotes generation of H2O2, we measured changes in mitochondrial H2O2 in ARTg and wild type mice hearts with and without pharmacological intervention. Under baseline conditions, mitochondrial H2O2 was significantly higher in ARTG mice hearts compared to WT hearts (Fig 5a) . Mitochondria from ARTg mice hearts subjected to I/R injury had significantly higher amounts of H2O2 compared to WT hearts (Fig. 5b) . Comparing ARTg vs WT, the net change in H2O2 generation was 0.021 nmoles/min/mg under baseline and 0.031 nmoles/min/mg under I/R conditions. Net change in H2O2 was 0.031 nmoles/min/mg comparing WT baseline vs WT I/R and 0.042 comparing ARTg baseline vs ARTg I/R. These data indicate that the increases in H2O2
were significantly greater in ARTg group compared to WT under all perfusion conditions. Pharmacological blockade of aldose reductase in ARTg mice hearts significantly reduced mitochondrial H2O2 in both perfusion conditions (Fig 5a,b) . These data demonstrating increases in MDA (Fig 4b) and H2O2 (Fig 5b) in ARTg hearts indicate increased cardiac oxidative stress in ARTg compared to WT mice.
Mitochondrial enzymes
To determine if aldose reductase pathway impacts activity of mitochondrial respiratory complexes, we measured activities of specific electron transport chain enzymes in wild type and ARTg mice hearts (Table I ). Citrate synthase activity was similar in mitochondria from wild type and ARTg mice hearts. Under baseline conditions, mitochondria from wild type and ARTg mice hearts exhibited similar activity profile for complexes I, IV, V, and CS. Upon ischemia-reperfusion, marked deficiencies in activity levels of mitochondrial complex I (33% in WT vs 92% in ARTg), complex IV (27% in WT vs 56% in ARTg) and complex V (70% in WT Vs 85% in ARTg) were observed in ARTg group in comparison with wild type littermate hearts. These enzyme deficits were noted using absolute specific activities for the enzymes or activity ratio to that of citrate synthase, a marker enzyme commonly used to normalize mitochondrial content (Table I ). These data indicate that the mitochondrial complexes in ARTg are more prone to damage than in the wild type mice when subjected to ischemiareperfusion. Pharmacological inhibition of aldose reductase blocked the reductions in activities of Complex I and V, but not IV, in ARTg mice hearts subjected to ischemiareperfusion. Thus, data presented here demonstrates that, mitochondrial oxidative phosphorylation enzyme changes are critically affected by myocardial ischemic injury in ARTg mice hearts.
Effect of ROS reduction on MPT and ischemic injury in ARTg mice hearts:
To determine if blockade of ROS generation during ischemia-reperfusion in ARTg hearts is, in part, responsible for MPT pore opening, we perfused hearts with resveratrol, a powerful antioxidant (fig 6a,b) . Resveratrol significantly reduced mitochondrial H2O2
after I/R stress in ARTg hearts (Fig 6b) . The reduction in mitochondrial H2O2 after I/R in ARTg hearts treated with resveratrol was associated with reduction in mitochondrial swelling (Fig cb) and attenuation of ischemic injury (Fig 6d) . These data demonstrate that ROS generation is a key mechanism by which MPT pore opens and mediates ischemic injury in ARTg hearts. 
DISCUSSION
Aldose reductase and MPT Pore
The data presented here show that the increased ischemic-reperfusion injury in ARTg mice hearts is associated with increased opening of the MPT pore. Thus, in the isolated perfused heart, the increased MPT pore opening, detected by 2-DG and calcium ( Figure 1 ) induced swelling was accompanied by increased injury and poor functional recovery ( Figure 2 ) after ischemia-reperfusion. Inhibition of aldose reductase using zopolrestat in ARTg hearts resulted in inhibition of MPT pore opening (Figure 1 ), decreased ischemic injury and improved functional recovery after ischemia-reperfusion (20) . In earlier studies, we have shown that AR activity and substrate flux via AR are several fold greater in ARTg mice hearts than in WT hearts (20) and that attenuation of these changes protects ARTg mice hearts from I/R injury. Therefore, this study links increased opening of the MPT pore to increases in AR activity and flux in ARTg mice hearts.
Several studies have shown that opening of MPT pore, indeed, plays an important role in ischemia-reperfusion injury (7, 11, 13, (15) (16) (17) 27, 29, 44) . Recent studies have demonstrated that blocking of MPT pore opening protects myocardium from ischemiareperfusion injury (7, 17, 27, 29, 44) . Studies have also demonstrated that the immunosuppressive drug CsA inhibits MPT pore opening and protects myocardium from ischemia-reperfusion injury (7, 17, 27, 29, 44) . Although CsA can exert additional inhibitory effects at higher doses, the concentrations employed in our study have been shown to be optimal for preferential inhibition of MPT pore (11, 37) . In our study we show that perfusion of ARTg mice hearts with CsA reduced ischemic injury and improved functional recovery on reperfusion. Within the limitations of the in vitro mitochondrial studies, the data presented here demonstrates that aldose reductase pathway mediates myocardial ischemic injury, in part, by opening MPT pore in mice hearts.
Aldose Reductase, ROS, MPT Pore, and ischemic injury
Several mechanisms can be postulated to explain the action by which AR might impact MPT pore opening. Foremost among them are the hypothesis that AR leads to glutathione depletion and increases ROS (58, 59) . For this reason we assessed the activity levels of oxidant stress enzymes in the hearts of mice prior to ischemia-reperfusion injury. Reductions in GSH and SOD activity are likely to favor increases in H2O2 in ARTg mice hearts, as shown in this study (Figure 5a ,b) are indicative of the high oxidant stress environment in amplifying injury in the ARTg mice hearts. In the myocardium accumulation of excessive ROS production has been linked to MPT pore opening and injury after I/R. In this study we demonstrate that mitochondrial H2O2 generation was significantly higher in ARTg mice hearts compared to wild type hearts under all perfusion conditions. It is evident from our data that net changes in mitochondrial H2O2 of 0.031 nmoles/min/mg or above elicits significant increases in MPT pore opening.
Further, we demonstrate that pharmacological blockade of aldose reductase in ARTg mice heart results in significant reduction of mitochondrial H2O2, attenuation of MPT pore opening, and reduction in injury after I/R. Similarly, perfusion with resveratrol was associated with reduction in mitochondrial H2O2, attenuation of MPT pore opening, and reduction in injury after I/R in ARTg mice hearts. Though resveratrol has been shown to mediate some of the beneficial effects via SIRT1 (31, 62) , reduction in oxidative stress and protection of ischemic hearts by resveratrol in this study is consistent with earlier studies demonstrating antioxidant properties of resveratrol in cardiac system (2,6,25,50).
Our findings here are consistent with the earlier studies (3, 55) demonstrating that increased oxidative stress is an important mechanism by which MPT pore opening is increased in ARTg hearts subjected to ischemia-reperfusion.
Our data presented here demonstrating increased oxidative stress in ARTg mice hearts subjected to ischemia-reperfusion are consistent with data from other studies that have implicated increases in flux via AR to increased oxidative stress. Studies by Iwata et al (26) demonstrated that aldose reductase overexpressing mouse hearts exhibit increased injury and poor functional recovery after myocardial ischemia-reperfusion and that these changes are due to increased oxidative stress. Mice expressing human aldose reductase exhibit greater injury and greater MDA content than wild type mice with lower aldose reductase activity (34) . It has also been shown that aldose reductase null mice exhibits reduced oxidative stress and is protected against ischemic injury (34) . In rat hearts subjected to ischemia-reperfusion, increases in polyol pathway activity have been shown to increase iron accumulation and exacerbation of oxidative damage (54) . Furthermore, studies have shown that aldose reductase inhibition in animals does not cause increases in lipid peroxidation products (4, 18, 32, 39) and that ARI-treated hyperglycemic animals show reductions in diabetic vascular complications and not accelerated pathological changes. Only discordant findings to date have been in a rabbit model of ischemic preconditioning by Shinmura et al (51) . Thus, overwhelming evidence in the literature support our findings demonstrating that AR increases oxidative stress under conditions of ischemia-reperfusion thereby contributing to increased injury.
Aldose Reductase and mitochondrial enzymes
Mitochondrial electron transport chain complexes are known to contribute to ROS production and to be impacted by continued production of ROS. In particular, potential contribution from Complex I, Complex III of electron transport chain, and mitochondrial glycerol phosphate dehydrogenase and succinate-ubiquinone oxido reductase towards electron leakage and ROS production has been widely described (24, 30, 33, 40, 41, 42) .
Ischemia-reperfusion injury has been shown to impair mitochondrial respiration by impacting oxidative phosphorylation enzymes in the mitochondria (9, 24, 30, 33, 40, 42) .
Complex I have previously been shown, in part, to be responsible for increased reactive oxygen species generation (1, 53, 57) . Inhibition of aldose reductase, in I/R, blocked reductions in Complex I and V activities, but not complex IV, in ARTg mice hearts (Table 1) . Since defects in mitochondrial ATPase has been associated with decrease in mitochondrial ATP content (19) , improved complex V activity with inhibition of aldose reductase may, in part, be responsible for improved ATP content in ARTg mice hearts after I/R (20) . The data presented in this study are consistent with earlier studies that have demonstrated link between increased generation of mitochondrial H2O2 and greater reductions in activities of complex I, IV, and V. While we have discussed potential pathways by which AR can impact ROS, the precise mechanisms by which AR increases ROS and the sequence of changes in mitochondrial complexes and or other components impacting oxidative stress are yet to be elucidated. Taken together, increased flux through polyol pathway enzyme, AR, is a major contributing factor towards mitochondrial dysfunction assessed by reduced activity levels of oxidative phosphorylation enzymes.
Future directions
While we have focused on the role of reactive oxygen species in opening MPT pore in ARTg mice hearts, other factors influencing MPT pore, such as in intracellular calcium, ATP depletion, cytosolic NADH/NAD+, NADPH and associated changes in protein kinases in cell death/survival signaling (28) needs to be explored.
In conclusion, this study demonstrates that MPT pore opening is a key event by which aldose reductase pathway mediates myocardial ischemia-reperfusion injury.
Furthermore, we show that the MPT pore opening after I/R is triggered, in part, by increases in reactive oxygen species generation in ARTg mice hearts. Therefore, inhibition of aldose reductase pathway protects mitochondria and hence, may be a useful adjunct for salvaging ischemic myocardium.
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